Bright Minds Biosciences Inc.
DRUG · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $6,820 | $8,077 | $21,007 | $81,241 |
| - Cash | $5,720 | $6,748 | $11,628 | $19,760 |
| + Debt | $119 | $74 | $140 | $0 |
| Enterprise Value | $1,219 | $1,402 | $9,519 | $61,481 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | -$7,280 | -$14,726 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$2,802 | -$7,372 | -$14,965 | -$8,651 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.65 | -1.98 | -6.15 | -4.74 |
| % Growth | 67.2% | 67.8% | -29.7% | – |
| Operating Cash Flow | -$1,850 | -$7,024 | -$13,587 | -$7,319 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$1,850 | -$7,024 | -$13,587 | -$7,319 |